ExploreWatchlistsPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Accounts receivable, net

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. (E25678)

Market cap
P/E ratio
Taisho Pharmaceutical Holdings develops and sells both over-the-counter and prescription medicines, along with health products, serving customers in Japan and internationally.
SummaryFinancialsDividendsHistoryWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 202352,300-2.56%
Mar 31, 202253,676+4.01%
Mar 31, 202151,609-21.16%
Mar 31, 202065,463-8.17%
Mar 31, 201971,286-5.29%
Mar 31, 201875,268+8.24%
Mar 31, 201769,535-7.59%
Mar 31, 201675,243-6.32%
Mar 31, 201580,321+2.31%
Mar 31, 201478,507-6.25%
Mar 31, 201383,739

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat